Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1995 Jan;33(1):126–130. doi: 10.1128/jcm.33.1.126-130.1995

Detection and quantitation of the glucuronoxylomannan-like polysaccharide antigen from clinical and nonclinical isolates of Trichosporon beigelii and implications for pathogenicity.

C A Lyman 1, S J Devi 1, J Nathanson 1, C E Frasch 1, P A Pizzo 1, T J Walsh 1
PMCID: PMC227893  PMID: 7535310

Abstract

Sera from patients with systemic infections caused by the opportunistic fungus Trichosporon beigelii have been shown to cross-react with anticryptococcal antibodies. We quantitatively compared the amounts of antigen produced and examined the expression of O-acetyl epitopes from 35 strains of T. beigelii isolated from deep and superficial infections. By counterimmunoelectrophoresis, 10 of 10 isolates from deep infections were positive for polysaccharide, compared with 7 of 13 isolates from superficial infections (P = 0.02). All 23 strains tested were positive for polysaccharide when screened by immunodot. By enzyme immunoassay, the cross-reactive antigen produced by deep isolates (n = 9) had a mean titer of 1:5,500. In contrast, superficial isolates (n = 22) produced significantly less antigen than the deep isolates (P < 0.001), with a mean titer of 1:700. Isolates from environmental sources (n = 3) were similar to the superficial isolates, with a mean titer of 1:600. The mean concentrations +/- standard errors of cross-reactive polysaccharide released by deep isolates and superficial isolates were 3.09 +/- 0.44 and 1.74 +/- 0.30 micrograms/ml, respectively, when measured by rocket immunoelectrophoresis (P = 0.02). O-Acetyl epitopes were detected on polysaccharide from 8 of 9 strains of T. beigelii isolated from deep sources, while only 2 of 12 superficial isolates expressed detectable O-acetyl epitopes (P = 0.01). Thus, while all isolates of T. beigelii tested were capable of producing glucuronoxylomannan-like cross-reactive antigen, pathogenic isolates produced significantly more antigen than superficial or environmental isolates. Furthermore, significantly more pathogenic isolates than superficial or environmental isolates expressed antigen that was O acetylated.

Full Text

The Full Text of this article is available as a PDF (230.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bannatyne R. M., Fong I. W., Cheng P., Capellan J. M. Mouse model for disseminated Trichosporon beigelii infection. Lab Anim Sci. 1992 Apr;42(2):168–169. [PubMed] [Google Scholar]
  2. Campbell C. K., Payne A. L., Teall A. J., Brownell A., Mackenzie D. W. Cryptococcal latex antigen test positive in patient with Trichosporon beigelii infection. Lancet. 1985 Jul 6;2(8445):43–44. doi: 10.1016/s0140-6736(85)90093-5. [DOI] [PubMed] [Google Scholar]
  3. Devi S. J., Schneerson R., Egan W., Ulrich T. J., Bryla D., Robbins J. B., Bennett J. E. Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity. Infect Immun. 1991 Oct;59(10):3700–3707. doi: 10.1128/iai.59.10.3700-3707.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Diamond R. D., Root R. K., Bennett J. E. Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro. J Infect Dis. 1972 Apr;125(4):367–376. doi: 10.1093/infdis/125.4.367. [DOI] [PubMed] [Google Scholar]
  5. Gokaslan A., Anaissie E. A novel murine model of disseminated trichosporonosis. Infect Immun. 1992 Aug;60(8):3339–3344. doi: 10.1128/iai.60.8.3339-3344.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gray L. D., Roberts G. D. Experience with the use of pronase to eliminate interference factors in the latex agglutination test for cryptococcal antigen. J Clin Microbiol. 1988 Nov;26(11):2450–2451. doi: 10.1128/jcm.26.11.2450-2451.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gu X. X., Tsai C. M., Karpas A. B. Production and characterization of monoclonal antibodies to type 8 lipooligosaccharide of Neisseria meningitidis. J Clin Microbiol. 1992 Aug;30(8):2047–2053. doi: 10.1128/jcm.30.8.2047-2053.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Guého E., Smith M. T., de Hoog G. S., Billon-Grand G., Christen R., Batenburg-van der Vegte W. H. Contributions to a revision of the genus Trichosporon. Antonie Van Leeuwenhoek. 1992 May;61(4):289–316. doi: 10.1007/BF00713938. [DOI] [PubMed] [Google Scholar]
  9. Haupt H. M., Merz W. G., Beschorner W. E., Vaughan W. P., Saral R. Colonization and infection with Trichosporon species in the immunosuppressed host. J Infect Dis. 1983 Feb;147(2):199–203. doi: 10.1093/infdis/147.2.199. [DOI] [PubMed] [Google Scholar]
  10. Hoy J., Hsu K. C., Rolston K., Hopfer R. L., Luna M., Bodey G. P. Trichosporon beigelii infection: a review. Rev Infect Dis. 1986 Nov-Dec;8(6):959–967. [PubMed] [Google Scholar]
  11. Kemker B. J., Lehmann P. F., Lee J. W., Walsh T. J. Distinction of deep versus superficial clinical and nonclinical isolates of Trichosporon beigelii by isoenzymes and restriction fragment length polymorphisms of rDNA generated by polymerase chain reaction. J Clin Microbiol. 1991 Aug;29(8):1677–1683. doi: 10.1128/jcm.29.8.1677-1683.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kozel T. R., Mastroianni R. P. Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis. Infect Immun. 1976 Jul;14(1):62–67. doi: 10.1128/iai.14.1.62-67.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kozel T. R., Pfrommer G. S., Guerlain A. S., Highison B. A., Highison G. J. Role of the capsule in phagocytosis of Cryptococcus neoformans. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 2):S436–S439. doi: 10.1093/cid/10.supplement_2.s436. [DOI] [PubMed] [Google Scholar]
  14. Lee J. W., Melcher G. A., Rinaldi M. G., Pizzo P. A., Walsh T. J. Patterns of morphologic variation among isolates of Trichosporon beigelii. J Clin Microbiol. 1990 Dec;28(12):2823–2827. doi: 10.1128/jcm.28.12.2823-2827.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lyman C. A., Walsh T. J. Phagocytosis of medically important yeasts by polymorphonuclear leukocytes. Infect Immun. 1994 Apr;62(4):1489–1493. doi: 10.1128/iai.62.4.1489-1493.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. McManus E. J., Bozdech M. J., Jones J. M. Role of the latex agglutination test for cryptococcal antigen in diagnosing disseminated infections with Trichosporon beigelii. J Infect Dis. 1985 Jun;151(6):1167–1169. doi: 10.1093/infdis/151.6.1167. [DOI] [PubMed] [Google Scholar]
  17. McManus E. J., Jones J. M. Detection of a Trichosporon beigelii antigen cross-reactive with Cryptococcus neoformans capsular polysaccharide in serum from a patient with disseminated Trichosporon infection. J Clin Microbiol. 1985 May;21(5):681–685. doi: 10.1128/jcm.21.5.681-685.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Melcher G. P., Reed K. D., Rinaldi M. G., Lee J. W., Pizzo P. A., Walsh T. J. Demonstration of a cell wall antigen cross-reacting with cryptococcal polysaccharide in experimental disseminated trichosporonosis. J Clin Microbiol. 1991 Jan;29(1):192–196. doi: 10.1128/jcm.29.1.192-196.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Melcher G. P., Rinaldi M. G., Frey C. L., Drutz D. J. Demonstration, by immunoelectronmicroscopy, of a cell wall antigen in Trichosporon beigelii that cross-reacts with Cryptococcus neoformans capsular polysaccharide. J Infect Dis. 1988 Oct;158(4):901–902. doi: 10.1093/infdis/158.4.901. [DOI] [PubMed] [Google Scholar]
  20. Ross A., Taylor I. E. Extracellular glycoprotein from virulent and avirulent Cryptococcus species. Infect Immun. 1981 Mar;31(3):911–918. doi: 10.1128/iai.31.3.911-918.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Walling D. M., McGraw D. J., Merz W. G., Karp J. E., Hutchins G. M. Disseminated infection with Trichosporon beigelii. Rev Infect Dis. 1987 Sep-Oct;9(5):1013–1019. doi: 10.1093/clinids/9.5.1013. [DOI] [PubMed] [Google Scholar]
  22. Walsh T. J., Lee J. W., Melcher G. P., Navarro E., Bacher J., Callender D., Reed K. D., Wu T., Lopez-Berestein G., Pizzo P. A. Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis. J Infect Dis. 1992 Jul;166(1):121–133. doi: 10.1093/infdis/166.1.121. [DOI] [PubMed] [Google Scholar]
  23. Walsh T. J., Melcher G. P., Lee J. W., Pizzo P. A. Infections due to Trichosporon species: new concepts in mycology, pathogenesis, diagnosis and treatment. Curr Top Med Mycol. 1993;5:79–113. [PubMed] [Google Scholar]
  24. Walsh T. J., Newman K. R., Moody M., Wharton R. C., Wade J. C. Trichosporonosis in patients with neoplastic disease. Medicine (Baltimore) 1986 Jul;65(4):268–279. doi: 10.1097/00005792-198607000-00005. [DOI] [PubMed] [Google Scholar]
  25. Watson K. C., Kallichurum S. Brain abscess due to Trichosporon cutaneum. J Med Microbiol. 1970 Feb;3(1):191–193. doi: 10.1099/00222615-3-1-191. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES